Jb Capital LLC Gilead Sciences, Inc. Transaction History

Jb Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$57.72 - $65.01 $217,200 - $244,632	-3,763 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$57.92 - $72.58 $23,168 - $29,032	-400 Reduced 9.61%	3,763 $224,000
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $4,541 - $5,154	-70 Reduced 1.65%	4,163 $302,000
Q3 2021 Dec 08, 2021	BUY	$67.69 - $73.03 $286,531 - $309,135	4,233 New	4,233 $296,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Jb Capital LLC with notifications on news.